Related Experiment Video
Updated: Aug 2, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Prevalence and Genotypes of Hepatitis C Infection Among Hemodialysis Patients in Bushehr, Iran
Reza Taherkhani1, Fatemeh Farshadpour1, Reza Asayesh1
1Department of Virology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Insights
Hepatitis C virus (HCV) infection affects 5.4% of hemodialysis patients in Bushehr, Iran, with Arab ethnicity a risk factor. Regular screening and prompt treatment are crucial for this vulnerable population.
Area of Science:
- Infectious Diseases
- Hepatology
- Public Health
Background:
- Hepatitis C virus (HCV) poses a significant global health challenge, particularly in vulnerable populations.
- Patients undergoing regular hemodialysis are at increased risk of acquiring infections due to frequent healthcare exposures.
Purpose of the Study:
- To determine the prevalence, genotype distribution, and risk factors of HCV infection among hemodialysis patients in Bushehr province, Iran.
- To compare HCV seroprevalence in hemodialysis patients with a control group.
Main Methods:
- A cross-sectional study involving chronic hemodialysis patients from three cities in Bushehr province.
- HCV infection was detected using Enzyme-linked immunosorbent assay (ELISA) for antibodies and semi-nested reverse transcription polymerase chain reaction (RT-PCR) for viral RNA.
- Sequencing was performed to identify HCV genotypes.
Main Results:
- The overall anti-HCV antibody seroprevalence was 5.4% (15/279), with 0.7% (2/279) having detectable HCV viremia (genotype 3a).
- Hemodialysis patients exhibited significantly higher HCV seroprevalence compared to the control group (p = 0.007).
- Arab ethnicity was associated with significantly higher anti-HCV seroprevalence (p = 0.026); no association was found with sex, age, education, dialysis duration, or transfusion history.
Conclusions:
- The study highlights a notable prevalence of HCV infection among hemodialysis patients in Bushehr.
- Regular screening for HCV in hemodialysis patients is recommended to facilitate early detection and treatment.
- Targeted interventions may be necessary for ethnic groups identified as having higher risk.
Objectives:
To investigate the prevalence, genotype distribution, and risk factors of hepatitis C virus (HCV) infection among patients undergoing regular hemodialysis in Bushehr province in southern Iran.
Methods:
All chronic hemodialysis patients from the cities of Dashtestan, Genaveh, and Bushehr participated in this study. Enzyme-linked immunosorbent assay was used to detect anti-HCV antibodies. Molecular detection of HCV infection was performed by semi-nested reverse transcription polymerase chain reaction assay, targeting 5' untranslated region and core region of the genome, and sequencing.
Results:
Of 279 hemodialysis patients, 15 (5.4%) were positive for anti-HCV antibodies, and two (0.7%) patients had HCV viremia with genotype 3a. The hemodialysis patients had a significantly higher seroprevalence of HCV than the control group (p =0.007). Patients with Arab ethnicity had significantly higher anti-HCV seroprevalence compared to those with Fars ethnicity (p =0.026). Anti-HCV seropositivity was not statistically associated with the patients' sex, age group, place of residence, level of education, duration of hemodialysis, or history of blood transfusion.
Conclusions:
Considering the high seroprevalence of HCV in hemodialysis patients, regular screening of these patients for HCV infection and prompt treatment of those found infected are recommended.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hepatic Drug Excretion: Influencing Factors

